Artemis Resources Limited — AGM Information 2013

Oct 27, 2013

==> picture [222 x 66] intentionally omitted <==

ARTEMIS RESOURCES LIMITED A B N 8 0 1 0 7 0 5 1 7 4 9

NOTICE OF ANNUAL GENERAL MEETING

The annual general meeting of the Company will be held in the Board Room of RSM Bird Cameron Partners at Level 12, 60 Castlereagh Street, Sydney NSW 2000 on 29 November 2013 at 3pm (EST).

This Notice of Annual General Meeting and Explanatory Memorandum should be read in its entirety. If Shareholders are in doubt as to how they should vote, they should seek advice from their accountant, solicitor or other professional adviser without delay.

1

A B N 8 0 1 0 7 0 5 1 7 4 9

ARTEMIS RESOURCES LIMITED

NOTICE OF GENERAL MEETING

Notice is hereby given that the annual general meeting of shareholders of Artemis Resources Limited ( Company ) will be held in the Board Room of RSM Bird Cameron Partners at Level 12, 60 Castlereagh Street, Sydney NSW 2000 on 29 November 2013 at 3pm (EST) ( General Meeting ).

The Explanatory Memorandum provides additional information on matters to be considered at the General Meeting and forms part of this Notice.

Terms and abbreviations used in this Notice are defined in Schedule 1.

AGENDA

Ordinary Business

Financial Report

To receive and consider the financial report of the Company and its controlled entities for the year ended 30 June 2013 together with the Directors’ report in relation to that financial year and the auditor’s report on the financial report.

1. Resolution 1 – Adoption of Remuneration Report (nonbinding vote)

To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution :

"That, for the purposes of Section 250R(2) of the Corporations Act and for all other purposes, the Company adopts the Remuneration Report.”

Short Explanation : The Corporations Act provides that a resolution that the remuneration report be adopted must be put to vote at a listed company’s annual general meeting. The vote on Resolution 1 is advisory only and does not bind the Directors or the Company.

2. Resolution 2 – Re-election of Director – George Frangeskides

To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution :

“That, for the purpose of clause 5 of the Constitution and for all other purposes, Mr George Frangeskides, a Director, retires by rotation, and being eligible, is reelected as a Director.”

2

3. Resolution 3 – Ratification of Prior Issue of 5,400,000 Shares

To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution :

"That, for the purposes of ASX Listing Rule 7.4 and all other purposes, Shareholders ratify the allotment and issue of 5,400,000 Shares to Advisors on the terms and conditions set out in the Explanatory Memorandum.”

4. Resolution 4 – Ratification of Prior Issue of 33,333,331 Shares

To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution :

"That, for the purposes of ASX Listing Rule 7.4 and all other purposes, Shareholders ratify the allotment and issue of 33,333,331 Shares to institutional and sophisticated investors on the terms and conditions set out in the Explanatory Memorandum.”

5. Resolution 5 – Ratification of Prior Issue of 33,333,332 Options

To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution :

"That, for the purposes of ASX Listing Rule 7.4 and all other purposes, Shareholders ratify the allotment and issue of 33,333,332 Options to institutional and sophisticated investors on the terms and conditions set out in the Explanatory Memorandum.”

6. Resolution 6 – Approval to Issue 200,000,000 Shares

To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution :

"That, for the purposes of ASX Listing Rule 7.1 and all other purposes, approval is given for the Directors to allot and issue 200,000,000 Shares on the terms and conditions set out in the Explanatory Memorandum."

7. Resolution 7 – Approval to Issue 100,000,000 Options

To consider and, if thought fit, to pass, with or without amendment, the following resolution as an Ordinary Resolution :

“That, for the purpose of ASX Listing Rule 7.1 and for all other purposes, Shareholders approve the allotment and issue of a total of 100,000,000 Options on the terms and conditions set out in the Explanatory Memorandum.”

3

8. Resolution 8 – Issue of Performance Rights to Executive Director – Guy Robertson

To consider and, if thought fit, to pass, with or without amendment, the following resolution as an Ordinary Resolution :

“That, for the purposes of ASX Listing Rule 10.14 and for all other purposes, approval be given for the grant to Guy Robertson of up to a maximum of five (5) million performance rights, and the issue to him of Shares on the vesting of those performance rights, pursuant to the Company’s Performance Rights Plan and in accordance with the terms and conditions summarised in the Explanatory Memorandum.”

9. Resolution 9 – Issue of Performance Rights to NonExecutive Director – George Frangeskides

To consider and, if thought fit, to pass, with or without amendment, the following resolution as an Ordinary Resolution :

“That, for the purposes of ASX Listing Rule 10.14 and for all other purposes, approval be given for the grant to George Frangeskides of up to a maximum of two (2) million performance rights, and the issue to him of Shares on the vesting of those performance rights, pursuant to the Company’s Performance Rights Plan and in accordance with the terms and conditions summarised in the Explanatory Memorandum.”

10. Resolution 10 – Issue of Performance Rights to Non- Executive Director – Shannon Coates

To consider and, if thought fit, to pass, with or without amendment, the following resolution as an Ordinary Resolution :

“That, for the purposes of ASX Listing Rule 10.14 and for all other purposes, approval be given for the grant to Shannon Coates of up to a maximum of two (2) million performance rights, and the issue to her of Shares on the vesting of those performance rights, pursuant to the Company’s Performance Rights Plan and in accordance with the terms and conditions summarised in the Explanatory Memorandum.”

4

SPECIAL BUSINESS

11. Resolution 11 – Approval of 10% Placement Issue

To consider and, if thought fit, to pass the following resolution as a Special Resolution :

"That, for the purposes of ASX Listing Rule 7.1A and all other purposes, approval is given for the Company to allot and issue equity securities up to 10% of the Company’s issued share capital (at the time of the issue) calculated in accordance with the formula prescribed in ASX Listing Rule 7.1A.2 and on the terms and conditions set out in the Explanatory Memorandum."

5

VOTING EXCLUSION STATEMENTS

Under ASX Listing Rule 14.11, the Company will disregard any votes cast on the Resolutions by the following persons:

**RESOLUTION **	PERSONS EXCLUDED FROM VOTING
1. Adoption of Remuneration Report	• A member of the key management personnel (KMP), details of whose remuneration are included in the Remuneration Report for the year ended 30 June 2013; or • Acloselyrelated party ofaKMP¹
3. Ratification of Issue of 5,400,000 Shares	• Any person who participated in the proposed issue; and • Any of their respective Associates.
4. Ratification of Issue of 33,333,331 Shares	• Any person who participated in the proposed issue; and • Any of their respective Associates.
5. Ratification of Issue of 33,333,332 Options	• Any person who participated in the proposed issue; and • Any of their respective Associates.
6. Approval to issue 200,000,000 Shares	• Any person who may participate in the proposed issue; • Any person who might obtain a benefit (other than a benefit solely in the capacity of a holder of ordinary shares) if the resolution is passed; and • Any oftheir respectiveAssociates.
7. Approval to Issue 100,000,000 Options	• Any person who may participate in the proposed issue; • Any person who might obtain a benefit (other than a benefit solely in the capacity of a holder of ordinary shares) if the resolution is passed; and • Any oftheir respectiveAssociates.
8. Issue of Performance Rights to Guy Robertson	•The Directors of the Company; and •Any of their Associates
9. Issue of Performance Rights to George Frangeskides	•The Directors of the Company; and •Any of their Associates
10. Issue of Performance Rights to Shannon Coates	•The Directors of the Company; and •Any of their Associates
11. Approval of 10% Placement Issue	• Any person who may participate in the proposed issue; • Any person who might obtain a benefit (other than a benefit solely in the capacity of a holder of ordinary shares) if the resolution is passed; and • Any oftheir respectiveAssociates.

However, the Company need not disregard a vote if:

• (a) It is cast by a person as proxy for a member who is entitled to vote, in accordance with the directions on the proxy appointment form; or

• (b) It is cast by the person chairing the meeting as proxy for a person who is entitled to vote, in accordance with a direction on the proxy form to vote as the proxy decides.

6

¹A closely related party of a member of the key management personnel means any of the following:

• a spouse, child or dependent of the member;

• a child or dependent of the member's spouse;

• anyone else who is one of the member's family and may be expected to influence, or be influenced by, the member in the member's dealings with the Company;

• a company the member controls; or

• a person prescribed by regulations (as at the date of this notice of meeting, no additional persons have been prescribed by regulation).

DETERMINATION OF MEMBERSHIP AND VOTING ENTITLEMENT

The Directors have determined that all the Shares that are quoted on the ASX at 7pm EST on 27 November 2013 shall, for the purposes of determining voting entitlements at the General Meeting, be taken to be held by the persons registered as holding the Shares at that time. The entitlement of Shareholders to vote at the Meeting will be determined by reference to that time.

How to Vote

You may vote at the Meeting by attending the Meeting in person or by proxy.

To vote in person, you must attend the Meeting on 29 November 2013 at 3Pm EST, which is to be held in the Board Room of RSM Bird Cameron Partners at Level 12, 60 Castlereagh Street, Sydney.

If you wish to vote by proxy, your proxy form must be received by the Company no later than 7pm EST on 27 November 2013.

PROXIES

Please note that:

• (a) A Shareholder entitled to attend and vote is entitled to appoint a proxy to attend and vote instead of the Shareholder;

• (b) Where the Shareholder is entitled to cast two or more votes, the Shareholder may appoint two proxies and may specify the proportion or number of votes each proxy is appointed to exercise;

• (c) If the Shareholder appoints two proxies and the appointment does not specify the proportion or number of the Shareholders votes each proxy may exercise half of the votes. Any fractions of votes brought about by the apportionment of a proxy will be disregarded;

• (d)

• A proxy need not be a Shareholder;

• (e) If your proxy chooses to vote, he/she must vote in accordance with your directions. If you have directed your proxy to vote, and they fail to attend the meeting or they choose not to vote on a poll, then the Chairman of the Meeting will vote your proxies as directed by you.

• (f) If you do not mark a box, your proxy may vote as they choose on that item. However, if you intend to appoint a member of the KMP as your proxy, please ensure that you direct them how to vote on resolutions 1,8,9 and 10.

7

• (g) If the Chairman of the Meeting is your proxy (or he becomes your proxy by default), you will be taken to have expressly authorised him to exercise your proxy in relation to Resolution 1 (Adoption of the Remuneration Report), and Resolutions 8,9 and 10 (Grant of Performance Rights to Directors) even though the Chairman is, and those items are, connected directly or indirectly with the remuneration of a member of the key management personnel of the Artemis Group. Shareholders will be informed of the proxy position and the manner in which the Chairman intends to vote undirected proxies at the meeting.

• (h) Any instrument of proxy deposited or received at the registered office of the Company in which the name of the appointee is not filled in, will be deemed to be given in favour of the Chairman of the Meeting;

• (i) Completed proxy forms (together with any authority under which the proxy was signed or a certified copy of the authority) must be returned before 7pm on 27 November 2013 in one of the following 3 ways:

• By mail to : Security Transfer Registrars 770 Canning Highway Applecross WA 6953

• • By facsimile: Security Transfer Registrars + (61) (0) 8 9315 2233

• • By email: registrar@securitytransfer.com.au

At the meeting, the Chairman will allow a reasonable opportunity for shareholders to ask questions about, or make comments on, the management of the Company and the Remuneration Report. Shareholders will also be given a reasonable opportunity at the meeting to ask the Company’s auditor, RSM Bird Cameron Partners, questions about the content of its report, and the conduct of its audit of the Company, for the year.

The enclosed proxy form provides further details on appointing proxies and lodging proxy forms.

BY ORDER OF THE BOARD OF DIRECTORS

==> picture [125 x 93] intentionally omitted <==

Guy Robertson Company Secretary Dated: 26 October 2013

8

Explanatory Memorandum

This Explanatory Memorandum has been prepared for the information of Shareholders in connection with the business specified to be conducted at the Annual General Meeting to be held in the Board Room of RSM Bird Cameron Partners at Level 12, 60 Castlereagh Street, Sydney NSW 2000 on 29 November 2013 at 3pm (EST).

The Directors recommend that Shareholders read this Explanatory Memorandum in full in conjunction with the accompanying Notice of which this Explanatory Memorandum forms a part.

Accounts and Reports

As required under Section 317 of the Corporations Act, the annual financial report (which includes the financial statements and Directors’ declarations) for the year ended 30 June 2013 will be laid before the Annual General Meeting.

Shareholders will be given the opportunity to ask questions and make comments about the reports or the Company generally, but there will be no formal resolution submitted to the Meeting.

1. Resolution 1 – Adoption of Remuneration Report (nonbinding vote)

1.1 General

The Corporations Act requires that at a listed company’s annual general meeting, a resolution that the remuneration report be adopted must be put to the shareholders. However, such a resolution is advisory only and does not bind the Directors or the Company.

If at least 25% of the votes cast on Resolution 1 are voted against adoption of the Remuneration Report at the Annual General Meeting, and then again at the Company's 2014 annual general meeting, the Company will be required to put to Shareholders a resolution proposing the calling of a general meeting to consider the appointment of directors of the Company ( Spill Resolution ).

If more than 50% of Shareholders vote in favour of the Spill Resolution, the Company must convene the general meeting ( Spill Meeting ) within 90 days of the Company's 2014 annual general meeting. All of the Directors who were in office when the Company's 2014 Directors' report was approved, other than the managing director of the Company, will cease to hold office immediately before the end of the Spill Meeting but may stand for re-election at the Spill Meeting. Following the Spill Meeting those persons whose election or reelection as Directors is approved will be the Directors of the Company.

The remuneration report sets out the Company’s remuneration arrangements for the Directors and senior management of the Company. The remuneration report is part of the Directors’ report contained in the annual financial report of the Company for the financial year ending 30 June 2013.

9

A reasonable opportunity will be provided for discussion of the remuneration report at the Annual General Meeting.

1.2 Proxy Restrictions

If the Chairman of the Meeting is your proxy (or he becomes your proxy by default), you will be taken to have expressly authorised him to exercise your proxy in relation to Resolution 1 even though the Chairman is, and this item is, connected directly or indirectly with the remuneration of a member of the key management personnel of the Artemis Group. Shareholders will be informed of the proxy position and the manner in which the Chairman intends to vote undirected proxies at the meeting.

1.3 Definitions

Key Management Personnel has the same meaning as in the accounting standards and broadly includes those persons having authority and responsibility for planning, directing and controlling the activities of the Company, directly or indirectly, including any director (whether executive or otherwise) of the Company.

Closely Related Party of a member of the Key Management Personnel means:

• (a) a spouse or child of the member;

• (b) a child of the member’s spouse;

• (c) a dependent of the member or the member’s spouse;

• (d) anyone else who is one of the member’s family and may be expected to influence the member, or be influenced by the member, in the member’s dealing with the entity;

• (e) a company the member controls; or

• (f) a person prescribed by the Corporations Regulations 2001 (Cth ).

Remuneration Report means the remuneration report set out in the Director’s report section of the Company’s annual financial report for the year ended 30 June 2013.

1.4 Directors’ Recommendation

Noting that each Director has a personal interest in their own remuneration from the Company as set out in the Remuneration Report, the Board recommends that Shareholders vote in favour of this resolution.

10

2. Resolution 2 – Re-election of Director – Mr George Frangeskides

2.1 Background

Pursuant to rule 5 of the Company’s Constitution Mr Frangeskides retires at the 2013 Annual General Meeting but, being eligible, offers himself for reelection.

A brief profile of Mr Frangeskides is included in the annual report.

2.2 Directors’ Recommendation

The Board (other than Mr Frangeskides) recommends that Shareholders vote in favour of this resolution.

3. Resolution 3 – Ratification of Issue of 5,400,000 Shares

3.1 General

Resolution 3 seeks ratification of the allotment and issue by the Company of 5,400,000 Shares issued to advisors in lieu of a cash payment. These Shares were issued within the Company’s existing capacity under ASX Listing Rule 7.1.

ASX Listing Rule 7.1 provides that a company must not, subject to specified exceptions, issue or agree to issue more equity securities during any 12 month period than that amount which represents 15% of the number of fully paid ordinary securities on issue at the commencement of that 12 month period.

ASX Listing Rule 7.4 provides that an issue by a company of equity securities made without approval under ASX Listing Rule 7.1 is treated as having been made with approval for the purposes of ASX Listing Rule 7.1 if the issue did not breach ASX Listing Rule 7.1 and the company’s members subsequently approve it.

While the outcome of Resolution 3 will have no effect on the issue of the Shares in question, Shareholder approval will restore the Company’s ability to issue further equity securities under ASX Listing Rule 7.1 in the next 12 months from the date of issue, to the extent of the 5,400,000 Shares.

3.2 Technical information required by ASX Listing Rule 7.5

Pursuant to and in accordance with ASX Listing Rule 7.5, the following information is provided in relation to the Placement:

• (a) The number of securities allotted

The number of Shares allotted and issued was 5,400,000.

11

• (b) Issue Price

The Shares were issued a deemed price of 1.0 cent per share.

• (c) Name of Allottees

The allotment was made to Somerley Limited, an advisor to the Company. No shares were issued to related parties.

• (d) Terms of the Securities

The Shares issued are fully paid ordinary shares in the capital of the Company issued on the same terms and conditions as the Company’s existing Shares.

• (e) Intended use of Funds Raised

No funds were received in respect of 5,400,000 shares. The shares were issued in lieu of a cash payment to the advisor.

• (f) Voting Exclusion

A voting exclusion statement forms part of this notice.

3.3 Directors’ Recommendation

The Board recommends that Shareholders vote in favour of this resolution.

4. Resolution 4 – Ratification of Issue of 33,333,331 Shares

4.1 General

Resolution 4 seeks ratification of the allotment and issue by the Company of 33,333,331 Shares to institutional and sophisticated investors. These Shares were issued within the Company’s existing capacity under ASX Listing Rule 7.1. For details of this issue see ASX announcement dated 28 August 2013 and Appendix 3B issued on 13 September 2013.

ASX Listing Rule 7.1 provides that a company must not, subject to specified exceptions, issue or agree to issue more equity securities during any 12 month period than that amount which represents 15% of the number of fully paid ordinary securities on issue at the commencement of that 12 month period.

ASX Listing Rule 7.4 provides that an issue by a company of equity securities made without approval under ASX Listing Rule 7.1 is treated as having been made with approval for the purposes of ASX Listing Rule 7.1 if the issue did not breach ASX Listing Rule 7.1 and the company’s members subsequently approve it.

While the outcome of Resolution 4 will have no effect on the issue of the Shares in question, Shareholder approval will restore the Company’s ability

12

to issue further equity securities under ASX Listing Rule 7.1 in the next 12 months from the date of issue, to the extent of the 33,333,331 Shares.

4.2 Technical information required by ASX Listing Rule 7.5

Pursuant to and in accordance with ASX Listing Rule 7.5, the following information is provided in relation to the Placement:

• (a) The number of securities allotted

• The number of Shares allotted and issued was 33,333,331.

• (b) Issue Price

The Shares were issued a price of 0.006 cents per share.

• (c) Name of Allottees The shares were allotted to institutional and professional investors. No shares were issued to related parties.

• (d) Terms of the Securities The Shares issued are fully paid ordinary shares in the capital of the Company issued on the same terms and conditions as the Company’s existing Shares.

• (e) Intended use of Funds Raised Funds received of $200,000 (before costs) will be used to fund a drilling programme at the Company’s Eastern Hills antimony project and for general working capital purposes.

• (f) Voting Exclusion A voting exclusion statement forms part of this notice.

4.3 Directors’ Recommendation

The Board recommends that Shareholders vote in favour of this resolution.

5. Resolution 5 - Ratification of issue of 33,333,332 options

5.1 Background

Under Resolution 5, the Company seeks Shareholder approval and ratification of the allotment and issue of 33,333,332 Options which occurred on 12 September 2013. For details of this issue see ASX announcement dated 28 August 2013 and Appendix 3B issued on 13 September 2013.

These Options were issued within the Company’s existing capacity under ASX Listing Rule 7.1.

5.2 ASX Listing Rule Requirements

ASX Listing Rule 7.1 provides, in summary, that a listed company may not issue equity securities in any 12 month period which, when aggregated with

13

the equity securities issued by a company during the previous 12 months, will exceed 15% of the total number of fully paid ordinary shares on issue in the company at the beginning of the 12 month period, except with the prior approval of Shareholders.

ASX Listing Rule 7.4 provides that an issue by a company of equity securities made without approval under ASX Listing Rule 7.1 is treated as having been made with approval for the purposes of ASX Listing Rule 7.1 if the issue did not breach ASX Listing Rule 7.1 and the company’s members subsequently approve it.

While the outcome of Resolution 5 will have no effect on the issue of the Shares in question, Shareholder approval will restore the Company’s ability to issue further equity securities under ASX Listing Rule 7.1 in the next 12 months from the date of issue, to the extent of the 33,333,332 Options.

5.3 ASX Listing Rule Disclosure Requirements

The following information is provided in accordance with ASX Listing Rule 7.5:

• (a) The number of equity securities allotted

The number of Options issued was 33,333,332.

• (b) The price at which the equity securities were issued

The Options were issued for no cash consideration. They were issued on the basis of one Short Dated Option and one Long Dated Option issued for every two shares issued (see resolution 4).

• (c) The terms of the equity securities

• (i) 16,666,666 Short Dated Options with an exercise price of 1.2 cents and expiry date 31 March 2014.

• (ii) 16,666,666 Long dated Options with an exercise price of 2 cents and an expiry date of 31 August 2016.

The detailed terms of the Options are set out in Annexure A and Annexure B.

• (d) The names of the allottees (if known) or the basis upon which the allottees will be identified or selected

The Options were issued to institutional and sophisticated investors. No options were issued to related parties.

• (e) The use (or intended use) of the funds raised

No funds were raised from the issue of the Options. The options were attached to Shares issued (see resolution 4) on the basis of one Short Dated and one Long Dated Option for every one Share issued.

14

5.4 Directors’ Recommendation

The Directors recommend that Shareholders vote in favour of Resolution 5 as it will allow the Company greater flexibility to issue further securities which could assist the Company to raise capital and to preserve cash resources.

6. Resolution 6 – Approval to Issue 200,000,000 Shares

6.1 Background

Resolution 6 seeks Shareholder approval for the allotment and issue of up to 200,000,000 Shares.

The Company may wish to undertake a capital raising by way of a placement to raise further funds. The Company seeks Shareholder approval under ASX Listing Rule 7.1 for a possible placement involving the issue of Shares.

The purpose of the placement would be to provide the Company with additional funding to enable the Company to continue with its planned exploration programs and to meet the Company’s working capital requirements.

6.2 ASX Listing Rule Requirements

ASX Listing Rule 7.1 provides, in summary, that a listed company may not issue equity securities in any 12 month period which, when aggregated with the equity securities issued by the company during the previous 12 months, will exceed 15% of the total number of fully paid ordinary shares on issue in the company at the beginning of the 12 month period, except with the prior approval of shareholders.

Resolution 6 seeks Shareholder approval under ASX Listing Rule 7.1 for the issue of 200,000,000 Shares.

The effect of the approval is that the Shares referred to in Resolution 6 will be not be counted as reducing the number of equity securities which the Company can issue without Shareholder approval under the limit imposed by ASX Listing Rule 7.1.

6.3 ASX Listing Rule Disclosure Requirements

The following information is provided in accordance with ASX Listing Rule 7.3:

• (a) The maximum number of equity securities the entity is to issue

The maximum number of Shares to be allotted and issued will be 200,000,000.

• (b) The date by which the entity will issue the equity securities

15

It is anticipated that, subject to Shareholder approval, the Shares will be allotted and progressively issued no later than three months after the date of the General Meeting, or such later date as approved by the ASX by way of the ASX granting a waiver under the ASX Listing Rules.

• (c) The issue price of the Equity Securities

The Shares will be issued at a price that is at least 80% of the volume weighted average market price for Shares, where the average is calculated, in accordance with ASX Listing Rule 7.3.3, over the last five days on which sales in Shares were recorded before the day on which the issue was made or, if there was a prospectus or offer information statement relating to the issue, over the last 5 days on which sales in the Shares were recorded before the date the prospectus or offer information statement is signed.

• (d) The names of the allottees (if known) or the basis upon which the allottees will be identified or selected

The allottees of the Shares are not currently known but will be institutional and sophisticated investors and will be selected on the basis of their ability to provide funding to the Company pursuant to the placement, if undertaken. None of these parties will be related parties or Associates of the Company.

• (e) The terms of the equity securities

The Shares will rank equally in all respects with existing Shares on issue.

• (f) The intended use of the funds raised

If undertaken, the funds to be raised by the Company in the placement would be intended to be used for the following purposes:

• (i) exploration expenditure in relation to the Company’s projects; and

• (ii) general working capital requirements of the Company.

• (g) The dates of allotment or a statement that allotment will occur progressively

See paragraph 6.3(b).

6.4 Directors’ Recommendation

The Directors recommend that Shareholders vote in favour of Resolution 6, as the placement, if undertaken, would provide the Company with necessary funds to enable it to continue with its exploration program and additional funding to meet the Company’s working capital requirements.

16

7. Resolution 7 – Approval to Issue 100,000,000 Options

7.1 Background

Under Resolution 7, the Company seeks Shareholder approval to issue and allot options, being a total of 100,000,000 Options having an exercise price of $0.007 cents per Option with an expiry date of 30 June 2014 and otherwise on the terms and conditions set out in Annexure C, to institutional and/or sophisticated investors.

7.2 ASX Listing Rule Requirements

ASX Listing Rule 7.1 provides, in summary, that a listed company may not issue equity securities in any 12 month period which, when aggregated with the equity securities issued by a company during the previous 12 months, will exceed 15% of the total number of fully paid ordinary shares on issue in the company at the beginning of the 12 month period, except with the prior approval of Shareholders.

Resolution 7 seeks Shareholder approval under ASX Listing Rule 7.1 for the issue of a total of 100,000,000 Options described above. The effect of such approval is that those Options will be not be counted as reducing the number of equity securities which the Company can issue without Shareholder approval under the limit imposed by ASX Listing Rule 7.1.

7.3 ASX Listing Rule Disclosure Requirements

The following information is provided in accordance with ASX Listing Rule 7.3:

• (a) The maximum number of equity securities the entity is to issue

The maximum number of securities to be issued is a total of 100,000,000 Options.

• (b) The date by which the entity will issue the equity securities

The Options will be issued no later than three months after the date of the Meeting, or such later date as may be approved by ASX.

• (c) The issue price of the equity securities

The options will be issued for $0.0001 each.

• (d) The names of the allottees (if known) or the basis upon which the allottees will be identified or selected

The allottees of the Options are not known but will be institutional and sophisticated Investors. Allottees will not be related parties of the Company.

• (e) The terms of the equity securities

The Options will be issued on the terms and conditions set out in Annexure C.

17

• (f) The intended use of the funds raised

$10,000 will be raised from the issue of the Options which will be applied to working capital. If all of the Options become exercisable and are exercised at a price of $0.007 cents per Option, $700,000 of additional funding will be raised for the Company which will be used for project development and working capital purposes.

(g) The dates of allotment or a statement that allotment will occur progressively

The Options will be allotted progressively.

• (h) Voting Exclusion

A voting exclusion statement forms part of the notice of meeting.

7.4 Directors' Recommendation

The Board recommends that Shareholders vote in favour of Resolution 7 as the issue of the proposed Options will assist the Company in achieving its capital raising and business objectives.

8. Resolution 8 – Approval of Performance Rights – Executive Director – Guy Robertson

8.1 Introduction

ASX Listing Rule 10.14 requires that an entity must not permit any of the following persons to acquire securities under an employee incentive scheme without the approval of holders of ordinary securities of the acquisition;

• A director of the entity

• An associate of the director

• A person whose relationship with the entity, is in ASX’s opinion, such that approval should be obtained.

The following information is provided in accordance with ASX Listing Rule 10.15.

Guy Robertson has acted as Executive Director of the Company since September 2011. The Company has agreed to grant Mr Robertson Performance Rights being rights to acquire Shares for nil consideration ( Performance Rights ) as part of his remuneration by the Company.

In introducing an equity component to his remuneration, the Company’s objective is to provide an added incentive to Mr Robertson to focus on the delivery of long term Shareholder returns. The Performance Rights will be issued under the EPRP subject to the necessary Shareholder approval.

18

The persons who are eligible to participate in the scheme are the Directors of the Company Mr Guy Robertson, Mr George Frangeskides and Ms Shannon Coates.

No securities have been issued under the Performance Rights Plan to date. The performance rights granted in November 2012 were not issued.

If approved by Shareholders, the Board intends to grant the Performance Rights as soon as reasonably practicable following the Annual General Meeting on the terms and conditions set out below.

8.2 Performance Rights

Performance Rights are to be granted in accordance with the following matrix.

The maximum rights to be granted is five (5) million. The rights are to be granted as soon as reasonably practical following the Annual General Meeting but will not vest until the performance hurdles have been met in accordance with the following matrix.

Outperformance ¹	Action A³	Action B³
>60%	3m	5m
>40%	2m	4m
>20%	1m	3m

¹ Performance Rights vest when Company outperforms its Peer² group in share price appreciation, based on VWAP (Volume Weighted Average Price) for a minimum of 60 days during the financial year and delivery of key milestones³.

² The Peer group includes several companies being gold explorers with a small market capitalisation.

³ Key milestones are:

Action A - JORC compliant resource on Artemis’ Eastern Hills project of at least 1 Mt at 2% Sb.

Action B – Introducing a strategic investor to one of Artemis’ projects with an investment of not less than $2 million.

On vesting each performance right is able to be converted into one ordinary share.

The performance rights will be granted on shareholder approval. However the performance rights will not vest until the hurdles outlined above have been achieved.

19

8.3 Performance Period and Vesting

The performance period is two years commencing 1 July 2013. Any Performance Rights which do not vest will lapse no later than 30 November 2015.

The securities (Performance Rights) will be granted no later than 12 months after the date of the meeting.

Shares allocated following the exercise of Performance Rights are subject to certain restrictions on disposal in accordance with the Performance Rights Plan and subject also to observance of the Company’s Share Trading Policy in dealing with Shares.

8.4 Other information

The Board of Directors have determined that amount of performance rights constitute reasonable remuneration in the event they were granted and shareholder approval under Chapter 2E of the Corporations Act 2001, is therefore not required.

No loan will be made to the Director in connection with the acquisition of the performance rights.

No amount is payable on the grant or vesting of Performance Rights.

Mr Robertson has no other equity base incentives.

9. Resolution 9 – Approval of Performance Rights – NonExecutive Director – George Frangeskides

9.1 Introduction

ASX Listing Rule 10.14 requires that an entity must not permit any of the following persons to acquire securities under an employee incentive scheme without the approval of holders of ordinary securities of the acquisition;

• A director of the entity

• An associate of the director

• A person whose relationship with the entity, is in ASX’s opinion, such that approval should be obtained.

The following information is provided in accordance with ASX Listing Rule 10.15.

George Frangeskides has acted as a Non-Executive Director of the Company since 15 August 2012. The Company has agreed to grant Mr Frangeskides Performance Rights being rights to acquire Shares for nil consideration ( Performance Rights ) as part of his remuneration by the Company.

In introducing an equity component to his remuneration, the Company’s objective is to provide an added incentive to Mr Frangeskides to focus on the

20

delivery of long term Shareholder returns. The Performance Rights will be issued under the EPRP subject to the necessary Shareholder approval.

The persons who are eligible to participate in the scheme are the Directors of the Company Mr Guy Robertson, Mr George Frangeskides and Ms Shannon Coates.

No securities have been issued under the Performance Rights Plan to date. The performance rights granted in November 2012 were not issued.

If approved by Shareholders, the Board intends to grant the Performance Rights as soon as reasonably practicable following the Annual General Meeting on the terms and conditions set out below.

9.2 Performance Rights

Performance Rights are to be granted in accordance with the following matrix.

The maximum rights to be granted is two (2) million. The rights are to be granted as soon as reasonably practical following the Annual General Meeting but will not vest until the performance hurdles have been met in accordance with the following matrix.

Outperformance¹	Action A³	Action B³
60%	1m	2m
40%	0.5m	1m
20%	0.25m	0.5m

¹ Performance Rights vest when Company outperforms its Peer² group in share price appreciation, based on VWAP (Volume Weighted Average Price) for a minimum of 60 days during the financial year and delivery of key milestones³.

² The Peer group includes several companies being gold explorers with a small market capitalisation

³ Key milestones are:

Action A - JORC compliant resource on Artemis’ Eastern Hills project of at least 1 Mt at 2% Sb.

Action B – Introducing a strategic investor to one of Artemis’ projects with an investment of not less than $2 million.

On vesting each performance right is able to be converted into one ordinary share.

The performance rights will be granted on shareholder approval. However the performance rights will not vest until the hurdles outlined above have been achieved.

21

9.3 Performance Period and Vesting

The performance period is two years commencing 1 July 2013. Any Performance Rights which do not vest will lapse no later than 30 November 2014.

The securities (Performance Rights) will be granted no later than 12 months after the date of the meeting.

Shares allocated following the exercise of Performance Rights are subject to certain restrictions on disposal as set out in the Performance Rights Plan and subject also to observance of the Company’s Share Trading Policy in dealing with Shares.

9.4 Other information

The Board of Directors have determined that amount of performance rights constitute reasonable remuneration in the event they were granted and shareholder approval under Chapter 2E of the Corporations Act, 2001 is therefore not required.

No loan will be made to the Director in connection with the acquisition of the performance rights.

No amount is payable on the grant or vesting of Performance Rights.

Mr Frangeskides has no other equity based incentives.

10. Resolution 10 – Approval of Performance Rights – NonExecutive Director – Shannon Coates

10.1 Introduction

ASX Listing Rule 10.14 requires that an entity must not permit any of the following persons to acquire securities under an employee incentive scheme without the approval of holders of ordinary securities of the acquisition;

• A director of the entity

• An associate of the director

• A person whose relationship with the entity, is in ASX’s opinion, such that approval should be obtained.

The following information is provided in accordance with ASX Listing Rule 10.15.

Shannon Coates has acted as a Non-Executive Director of the Company since 28 September 2011. The Company has agreed to grant Ms Shannon Coates Performance Rights being rights to acquire Shares for nil consideration ( Performance Rights ) as part of her remuneration by the Company.

22

In introducing an equity component to his remuneration, the Company’s objective is to provide an added incentive to Ms Coates to focus on the delivery of long term Shareholder returns. The Performance Rights will be issued under the EPRP subject to the necessary Shareholder approval.

The persons who are eligible to participate in the scheme are the Directors of the Company Mr Guy Robertson, Mr George Frangeskides and Ms Shannon Coates.

No securities have been issued under the Performance Rights Plan to date.

If approved by Shareholders, the Board intends to grant the Performance Rights as soon as reasonably practicable following the Annual General Meeting on the terms and conditions set out below.

10.2 Performance Rights

Performance Rights are to be granted in accordance with the following matrix.

The maximum rights to be granted is two (2) million. The rights are to be granted as soon as reasonably practical following the Annual General Meeting but will not vest until the performance hurdles have been met in accordance with the following matrix.

Outperformance¹	Action A³	Action B³
60%	1m	2m
40%	0.5m	1m
20%	0.25m	0.5m

¹ Performance Rights vest when Company outperforms its Peer² group in share price appreciation, based on VWAP (Volume Weighted Average Price) for a minimum of 60 days during the financial year and delivery of key milestones³.

² The Peer group includes several companies being gold explorers with a small market capitalisation

³ Key milestones are:

Action A - JORC compliant resource on Artemis’ Eastern Hills project of at least 1 Mt at 2% Sb.

Action B – Introducing a strategic investor to one of Artemis’ projects with an investment of not less than $2 million.

On vesting each performance right is able to be converted into one ordinary share.

23

The performance rights will be granted on shareholder approval. However the performance rights will not vest until the hurdles outlined above have been achieved.

10.3 Performance Period and Vesting

The performance period is two years commencing 1 July 2013. Any Performance Rights which do not vest will lapse no later than 30 November 2014.

The securities (Performance Rights) will be granted no later than 12 months after the date of the meeting.

Shares allocated following the exercise of Performance Rights are subject to certain restrictions on disposal as set out in the Performance Rights Plan and subject also to observance of the Company’s Share Trading Policy in dealing with Shares.

10.4 Other information

The Board of Directors have determined that amount of performance rights constitute reasonable remuneration in the event they were granted and shareholder approval under Chapter 2E of the Corporations Act, 2001 is therefore not required.

No loan will be made to the Director in connection with the acquisition of the performance rights.

No amount is payable on the grant or vesting of Performance Rights.

Ms Coates has no other equity based incentives.

SPECIAL BUSINESS

11. Resolution 11 – Approval of 10% Placement Issue

11.1 Background

ASX Listing Rule 7.1A enables eligible entities to issue Equity Securities up to 10% of their issued capital through placements over a twelve month period after the Annual General Meeting ( 10% Placement Facility ). The 10% Placement Facility is in addition to the Company’s 15% placement capacity under ASX Listing Rule 7.1.

An eligible entity for the purposes of ASX Listing Rule 7.1A is an entity that is not included in the S&P/ASX 300 Index and has a market capitalisation of $300 million or less. The Company is an eligible entity.

The effect of Resolution 11 will be to allow the Directors to issue the Equity Securities under ASX Listing Rule 7.1A during the 10% Placement Period (as defined below) separate to the Company’s 15% placement capacity under ASX Listing Rule 7.1.

24

The Company is now seeking Shareholder approval by way of a special resolution to have the ability to issue Equity Securities under the 10% Placement Facility. Resolution 11 is a special resolution and therefore requires approval of 75% of the votes cast by Shareholders present and eligible to vote (in person, by proxy, by attorney or, in the case of a corporate Shareholder, by a corporate representative).

The exact number of Equity Securities (if any) to be issued under the 10% Placement Facility will be determined in accordance with the formula prescribed in ASX Listing Rule 7.1.A.2 (refer to Section 10.2(c) below). The Company may use funds raised from any 10% Placement Facility for funding specific projects and/or general working capital. It may also use the 10% Placement Facility for non cash consideration purposes such as joint venture or project acquisitions (although the Company presently has no intention to do so).

The Directors of the Company believe that Resolution 11 is in the best interests of the Company and unanimously recommend that Shareholders vote in favour of this resolution.

11.2 ASX Listing Rule 7.1.A

(a) Shareholder approval

The ability to issue Equity Securities under the 10% Placement Facility is subject to Shareholder approval by way of a special resolution at an annual general meeting.

(b) Equity Securities

Any Equity Securities issued under the 10% Placement Facility must be in the same class as an existing quoted class of Equity Securities of the Company.

The Company, as at the date of the Notice, has three classes of Equity Securities being , Shares (ARV), Short Dated Listed Options (ARVO) and Long Dated Listed Options (ARVOA).

(c) Formula for calculating 10% Placement Facility

ASX Listing Rule 7.1A.2 provides that eligible entities which have obtained shareholder approval at an annual general meeting may issue or agree to issue, during the 12 month period after the date of the annual general meeting, a number of Equity Securities calculated in accordance with the following formula:

(A x D) – E

A is the number of shares on issue 12 months before the date of the issue or agreement:

• (i) plus the number of fully paid shares issued in the 12 months under an exception in ASX Listing Rule 7.2;

25

• (ii) plus the number of partly paid shares that became fully paid in the 12 months;

• (iii) plus the number of fully paid shares issued in the 12 months with approval of holders of shares under ASX Listing Rules 7.1 and 7.4;

• (iv) less the number of fully paid shares cancelled in the 12 months.

Note: A has the same meaning in ASX Listing Rule 7.1 when calculating an entity’s 15% placement capacity.

D is 10%

• E is the number of Equity Securities issued or agreed to be issued under ASX Listing Rule 7.1A.2 in the 12 months before the date of the issue or agreement to issue that are not issued with the approval of shareholders under ASX Listing Rules 7.1 or 7.4.

(d) ASX Listing Rule 7.1 and ASX Listing Rule 7.1A

The ability of an entity to issue Equity Securities under ASX Listing Rule 7.1A is in addition to the entity’s 15% placement capacity under ASX Listing Rule 7.1.

The actual number of Equity Securities that the Company will have capacity to issue under ASX Listing Rule 7.1A will be calculated at the date of issue of the Equity Securities in accordance with the formula prescribed in ASX Listing Rule 7.1A.2 (refer to Section 10.2(c) above).

(e) Minimum Issue Price

The issue price of Equity Securities issued under ASX Listing Rule 7.1A must be not less than 75% of the volume weighted average price of Equity Securities in the same class calculated over the 15 Trading Days (as defined in the ASX Listing Rules) immediately before:

(i) the date on which the price at which the Equity Securities are to be issued is agreed; or

(ii) if the Equity Securities are not issued within 5 Trading Days of the date in paragraph (i) above, the date on which the Equity Securities are issued.

(f) 10% Placement Period

Shareholder approval of the 10% Placement Facility under ASX Listing Rule 7.1A is valid from the date of the annual general meeting at which the approval is obtained and expires on the earlier to occur of:

(i) the date that is 12 months after the date of the annual general meeting at which the approval is obtained; or

(ii) the date of the approval by shareholders of a transaction under ASX Listing Rules 11.1.2 (a significant change to the nature or scale of activities) or 11.2 (disposal of main undertaking),

(the 10% Placement Period ).

11.3 Specific Information required by ASX Listing Rule 7.3A

Pursuant to and in accordance with ASX Listing Rule 7.3A, information is provided in relation to the approval of the 10% Placement Facility as follows:

26

(a) Minimum Price

Any Equity Securities issued will be issued at an issue price of not less than 75% of the volume weighted average price for the Company’s Equity Securities over the 15 Trading Days immediately before:

(i) the date on which the price at which the Equity Securities are to be issued is agreed; or

(ii) if the Equity Securities are not issued within 5 Trading Days of the date in paragraph (i) above, the date on which the Equity Securities are issued.

(b) Risk of Voting Dilution

If Resolution 11 is approved by the Shareholders and the Company issues Equity Securities under the 10% Placement Facility, the existing Shareholders’ voting power in the Company would be diluted as shown in the below table (in the case of listed/unlisted options, only if the listed/unlisted options are exercised). There is a risk that:

(i) the market price for the Company’s Equity Securities may be significantly lower on the date of the issue of the Equity Securities than on the date of the Meeting; and

(ii) the Equity Securities may be issued at a price that is at a discount to the market price for the Company’s Equity Securities on the issue date, which may have an effect on the amount of funds raised by the issue of the Equity Securities.

The table below shows the dilution of existing Shareholders on the basis of the current market price of Shares and the current number of ordinary securities for variable “A” calculated in accordance with the formula in ASX Listing Rule 7.1A(2) as at the date of this Notice of Meeting.

The table also shows:

(i) two examples where variable “A” has increased by 50% and 100%. Variable “A” is based on the number of ordinary shares the Company has on issue. The number of ordinary securities on issue may increase as a result of issues of ordinary securities that do not require Shareholder approval (for example, a pro rata entitlements issue or scrip issued under a takeover offer) or future specific placements under ASX Listing Rule 7.1 that are approved at a future Shareholders’ meeting; and

(ii) two examples of where the price of ordinary securities has decreased by 50% and increased by 100% as against the current market price.

27

Variable “A” in ASX Listing Rule 7.1A.2			Dilution
		50% decrease in Deemed Price $0.0025	Deemed Price $0.005	100% Increase in Deemed Price $0.01
Current Variable A 484,890,396 Shares	10% Voting Dilution	48,489,039 shares	48,489,039 shares	48,489,039 shares
	Funds Raised	$121,223	$242,445	$484,890
50% increase in current Variable A 727,335,594 shares	10% Voting _Dilution _	72,733,559 shares	72,733,559 shares	72,733,559 shares
	Funds Raised	$181,834	$363,668	$727,336
100% increase in current Variable A 969,780,792 Shares	10% Voting Dilution	96,978,079 shares	96,978,079 shares	96,978,079 shares
	Funds Raised	$242,445	$484,890	$969,781

The table has been prepared on the following assumptions:

(i) The Company issues the maximum securities available under the ASX Listing Rule 7.1A being 10% of the Company’s shares on issue at the date of the Meeting;

(ii) No listed/unlisted options are exercised into fully paid ordinary securities before the date of the issue of securities under ASX Listing Rule 7.1A. The Company has 20,000,000 unlisted options on issue at the date of this Notice of Meeting and 253,693,904 listed options on issue at the date of this Notice of Meeting;

(iii) The table does not demonstrate an example of dilution that may be caused to a particular shareholder by reason of placements under ASX Listing Rule 7.1A, based on that shareholder’s holding at the date of the Meeting;

(iv) The table only demonstrates the effect of issues of securities under ASX Listing Rule 7.1A. It does not consider placements made under ASX Listing Rule 7.1, the “15% rule”;

(v) The price of ordinary securities is deemed for the purposes of the table above to be $0.005 cents, being the closing price of the Company’s listed securities on ASX on 4 October 2013 ( Deemed Price ). The Deemed Price is indicative only and does not consider the 25% discount to market that the securities may be placed at;

(vi) The table does not demonstrate the effect of listed options being issued under ASX Listing Rule 7.1A. It only considers the issue of the fully paid ordinary securities.

(c) Date of Issue

The Company will only issue and allot the Equity Securities during the 10% Placement Period. The approval under Resolution 11 for the issue of the Equity Securities will cease to be valid in the event that Shareholders approve a transaction under ASX Listing Rule 11.1.2 (a significant change to the nature or scale of activities or ASX Listing Rule 11.2 (disposal of main undertaking).

(d) Purpose of the issue under the 10% Placement capacity

The Company may seek to issue the Equity Securities for the following purposes:

28

(i) non-cash consideration including for joint venture, licensing or collaboration agreements or the acquisition of new projects (although the Company presently has no proposal to do so). In such circumstances the Company will provide a valuation of the non cash consideration as required by ASX Listing Rule 7.1A.3; or

(ii) cash consideration. In such circumstances, the Company intends to use the funds raised towards advancing specific Company projects and/or general working capital.

The Company will comply with the disclosure obligations under ASX Listing Rules 7.1A(4) and 3.10.5A upon issue of any Equity Securities.

(e) Allocation Policy

The Company’s allocation policy is dependent on the prevailing market conditions at the time of any proposed issue pursuant to the 10% Placement Facility. The identity of the allottees of Equity Securities will be determined on a case by case basis having regard to factors including but not limited to the following:

(i) the methods of raising funds that are available to the Company, including but not limited to, rights issues or other issues in which existing security holders can participate;

(ii) the effect of the issue of the Equity Securities on the control of the Company;

(iii) the financial situation and solvency of the Company; and

(iv) advice from corporate, financial and broking advisers (if applicable).

The allottees under the 10% Placement Facility have not been determined as at the date of this Notice of Meeting but may include existing substantial Shareholders and/or new Shareholders who are not related parties or associates of a related party of the Company.

Further, if the Company were to pursue an acquisition and were it to be successful in acquiring new resources assets or investments, it is possible that the allottees under the 10% Placement Facility will be the vendors of the new resources assets or investments.

(f) Previous Approval

The Company previously obtained Shareholder approval under ASX Listing Rule 7.1A on 29 November 2012.

The total number of Equity Securities issued in the 12 months preceding the date of the Meeting is 516,287,913 representing 102.2% of the total number of Equity Securities on issue at the commencement of that 12 month period.

The details of all issues of Equity Securities by the Company during the 12 months preceding the date of the Meeting is set out in schedule 2 to this Explanatory Memorandum.

(g) Voting Exclusion

A voting exclusion statement is included in the Notice of Meeting to which this Explanatory Memorandum relates. At the date of that Notice, the Company has not approached any particular existing Shareholder or security holder or an identifiable class of existing security holder to participate in the issue of the Equity Securities. No existing Shareholder’s votes will therefore be excluded under the voting exclusion in the Notice.

The Directors unanimously recommend Shareholders vote in favour of Special Resolution 11.

29

Schedule 1 - Definitions

In this Explanatory Memorandum and Notice of General Meeting:

ASIC means Australian Securities and Investments Commission.

Associates has the meaning given by Sections 10 to 17 of the Corporations Act.

ASX means ASX Limited ACN 008 624 691 and the market operated by it, as the context requires.

ASX Listing Rules means the Listing Rules of ASX and any other rules of ASX which are applicable while the entity is admitted to the official list of ASX, each as amended or replaced from time to time except to the extent of any express written waiver by ASX.

Board means the Board of Directors of the Company.

Company or Artemis means Artemis Resources Limited ABN 80 107 051 749.

Constitution means the constitution of the Company.

Corporations Act means the Corporations Act 2001 (Cth).

Directors means the directors of the Company.

Equity Securities has the same meaning as in the Listing Rules;

EPRP means Executive Performance Rights Plan.

EST means Eastern Standard Time, in Sydney, New South Wales.

Explanatory Memorandum means the explanatory memorandum which accompanies and forms part of this Notice.

Key Management Personnel has the same meaning as in the accounting standards and broadly includes those persons having authority and responsibility for planning, directing and controlling the activities of the Company, directly or indirectly, including any director (whether executive or otherwise) of the Company.

General Meeting or Meeting means the annual general meeting of the Company to be held on 29 November 2013 at 3pm (EST), convened by this Notice.

Long Date Option means an Option with exercise price of 2 cents and expiring 31 August 2016

Notice means this Notice of General Meeting.

Option means an option to subscribe for a Share.

Resolution means each resolution to be considered at the Meeting.

Share means a fully paid ordinary share in the capital of the Company.

Short Dated Option means an Option with an exercise price of 1.2 cents and expiring 31 March 2014.

Securities means Shares and/or Options.

Shareholder means a holder of a Share.

In this Notice, words importing the singular include the plural and vice versa

30

Annexure A (Resolution 5)

The terms and conditions of the Annexure A (Short Dated) Options shall be as follows:

• (a) Each Annexure A Option entitles the holder to acquire one (1) Share.

• (b) The Annexure A Options are exercisable at any time from the Annexure A Option Vesting Date until 5.00pm EST on 31 March 2014 ( Annexure A Option Exercise Period ) by completing an Annexure A Option exercise form and delivering it together with the payment for the number of Shares in respect of which the Annexure A Options are exercised to the registered office of Artemis or to the share registry of Artemis.

• (c) The Annexure A Options vest on the date of Grant ( Annexure A Option Vesting Date ):

• (d) The Annexure A Option exercise price is $0.012 per Option.

• (e) On and from the relevant Annexure A Option Vesting Date, the Annexure A Options will be freely transferable in whole or in part at any time prior to expiry.

• (f) Shares issued on the exercise of an Annexure A Option will be issued not more than fourteen (14) days after receipt of a properly executed exercise notice and application moneys. Shares allotted pursuant to the exercise of an Annexure A Option will rank equally with the then issued ordinary shares of the Company in all respects. Official Quotation of those Shares on the ASX will be sought.

• (g) Annexure A Option holders shall be permitted to participate in new issues of securities on the prior exercise of Annexure A Options in which case the Annexure A Option holders shall be afforded the period of at least nine (9) business days prior to and inclusive of the record date (to determine entitlements to the issue) to exercise their Annexure A Options.

• (h) In the event of any reconstruction (including consolidation, sub-division, reduction or return) of the issued capital of the Company, all rights of the Annexure A Option holder will be changed to the extent necessary to comply with the ASX Listing Rules applying to the reconstruction of capital at the time of the reconstruction.

• (i) If there is a bonus issue to Shareholders, the number of Shares over which the Annexure A Option is exercisable may be increased by the number of Shares which the holder of the Annexure A Option would have received if the Annexure A Option had been exercised before the record date for the bonus issue.

• (j) In the event that a pro rata issue (except a bonus issue) is made to the holders of the underlying securities in the Company, the exercise price of the Annexure A Option may be reduced in accordance with ASX Listing Rule 6.22.

• (k) Reminder notices will be forwarded to the Annexure A Option holders prior to the expiry of the Annexure A Options. Annexure A Options not exercised before the expiry of the Annexure A Option Exercise Period will lapse.

• (l) The Annexure A Options will be recorded on the Company's register of Option holders maintained at the share registry. The register will be open for inspection

31

by an Annexure A Option holder free of charge. Shares to be allotted on exercise of Annexure A Options will be recorded on the Company's share register.

• (m) The Directors may seek quotation of the Annexure A Options on the ASX.

• (n) The Annexure A Option holder, if appearing on the Company's register of Option holders at the relevant date, will be entitled to receive and will be sent all reports and accounts required to be laid before Shareholders in general meeting and all notices of general meetings and will have the right to attend but shall have no right to vote at such meetings.

• (o) Notwithstanding paragraph (c), all Annexure A Options may be exercised prior to the relevant Annexure A Option Vesting Date:

• (i) in relation to a takeover bid in respect of the Shares, during the bid period, as defined in section 9 of the Corporations Act, provided that where a takeover bid is publicly announced prior to the service of a bidder's statement on the Company in relation to that takeover bid, the bid period will be deemed to have commenced at the date of that announcement;

• (ii) at any time after a Shareholder, or a group of associated Shareholders, becomes entitled to sufficient Shares to give it or them the ability, and that ability is successfully exercised, in general meeting, to replace all or a majority of the Directors;

• (iii) at any time after, on an application under section 411 of the Corporations Act, a court orders a meeting to be held concerning a proposed compromise or arrangement for the purposes of, or in connection with, a scheme for the reconstruction of the Company, or its amalgamation with any other company.

32

Annexure B (Resolution 5)

The terms and conditions of the Annexure B (Long Dated) Options shall be as follows:

• (a) Each Annexure B Option entitles the holder to acquire one (1) Share.

• (b) The Annexure B Options are exercisable at any time from the Annexure B Option Vesting Date until 5.00pm EST on 31 August 2016 ( Annexure B Option Exercise Period ) by completing an Annexure B Option exercise form and delivering it together with the payment for the number of Shares in respect of which the Annexure B Options are exercised to the registered office of Artemis or to the share registry of Artemis.

• (c) The Annexure B Options vest on the date of Grant ( Annexure B Option Vesting Date ):

• (d) The Annexure B Option exercise price is $0.02 per Option.

• (e) On and from the relevant Annexure B Option Vesting Date, the Annexure B Options will be freely transferable in whole or in part at any time prior to expiry.

• (f) Shares issued on the exercise of an Annexure B Option will be issued not more than fourteen (14) days after receipt of a properly executed exercise notice and application moneys. Shares allotted pursuant to the exercise of an Annexure B Option will rank equally with the then issued ordinary shares of the Company in all respects. Official Quotation of those Shares on the ASX will be sought.

• (g) Annexure B Option holders shall be permitted to participate in new issues of securities on the prior exercise of Annexure B Options in which case the Annexure B Option holders shall be afforded the period of at least nine (9) business days prior to and inclusive of the record date (to determine entitlements to the issue) to exercise their Annexure B Options.

• (h) In the event of any reconstruction (including consolidation, sub-division, reduction or return) of the issued capital of the Company, all rights of the Annexure B Option holder will be changed to the extent necessary to comply with the ASX Listing Rules applying to the reconstruction of capital at the time of the reconstruction.

• (i) If there is a bonus issue to Shareholders, the number of Shares over which the Annexure B Option is exercisable may be increased by the number of Shares which the holder of the Annexure B Option would have received if the Annexure B Option had been exercised before the record date for the bonus issue.

• (j) In the event that a pro rata issue (except a bonus issue) is made to the holders of the underlying securities in the Company, the exercise price of the Annexure B Option may be reduced in accordance with ASX Listing Rule 6.22.

• (k) Reminder notices will be forwarded to the Annexure B Option holders prior to the expiry of the Annexure B Options. Annexure B Options not exercised before the expiry of the Annexure B Option Exercise Period will lapse.

• (l) The Annexure B Options will be recorded on the Company's register of Option holders maintained at the share registry. The register will be open for inspection by an Annexure B Option holder free of charge. Shares to be allotted on exercise of Annexure B Options will be recorded on the Company's share register.

33

• (m) The Directors may seek quotation of the Annexure B Options on the ASX.

• (n) The Annexure B Option holder, if appearing on the Company's register of Option holders at the relevant date, will be entitled to receive and will be sent all reports and accounts required to be laid before Shareholders in general meeting and all notices of general meetings and will have the right to attend but shall have no right to vote at such meetings.

• (o) Notwithstanding paragraph (c), all Annexure B Options may be exercised prior to the relevant Annexure B Option Vesting Date:

• (i) in relation to a takeover bid in respect of the Shares, during the bid period, as defined in section 9 of the Corporations Act, provided that where a takeover bid is publicly announced prior to the service of a bidder's statement on the Company in relation to that takeover bid, the bid period will be deemed to have commenced at the date of that announcement;

• (ii) at any time after a Shareholder, or a group of associated Shareholders, becomes entitled to sufficient Shares to give it or them the ability, and that ability is successfully exercised, in general meeting, to replace all or a majority of the Directors;

• (iii) at any time after, on an application under section 411 of the Corporations Act, a court orders a meeting to be held concerning a proposed compromise or arrangement for the purposes of, or in connection with, a scheme for the reconstruction of the Company, or its amalgamation with any other company.

34

Annexure C (Resolution 7)

The terms and conditions of the Annexure C Options shall be as follows:

• (a) Each Annexure C Option entitles the holder to acquire one (1) Share.

• (b) The Annexure C Options are exercisable at any time from the Annexure C Option Vesting Date until 5.00pm EST on 30 June 2014 ( Annexure C Option Exercise Period ) by completing an Annexure C Option exercise form and delivering it together with the payment for the number of Shares in respect of which the Annexure C Options are exercised to the registered office of Artemis or to the share registry of Artemis.

• (c) The Annexure C Options vest on the date of Grant ( Annexure C Option Vesting Date ):

• (d) The Annexure C Option exercise price is $0.007 per Option.

• (e) On and from the relevant Annexure C Option Vesting Date, the Annexure C Options will be freely transferable in whole or in part at any time prior to expiry.

• (f) Shares issued on the exercise of an Annexure C Option will be issued not more than fourteen (14) days after receipt of a properly executed exercise notice and application moneys. Shares allotted pursuant to the exercise of an Annexure C Option will rank equally with the then issued ordinary shares of the Company in all respects. Official Quotation of those Shares on the ASX will be sought.

• (g) Annexure C Option holders shall be permitted to participate in new issues of securities on the prior exercise of Annexure C Options in which case the Annexure C Option holders shall be afforded the period of at least nine (9) business days prior to and inclusive of the record date (to determine entitlements to the issue) to exercise their Annexure C Options.

• (h) In the event of any reconstruction (including consolidation, sub-division, reduction or return) of the issued capital of the Company, all rights of the Annexure C Option holder will be changed to the extent necessary to comply with the ASX Listing Rules applying to the reconstruction of capital at the time of the reconstruction.

• (i) If there is a bonus issue to Shareholders, the number of Shares over which the Annexure C Option is exercisable may be increased by the number of Shares which the holder of the Annexure C Option would have received if the Annexure C Option had been exercised before the record date for the bonus issue.

• (j) In the event that a pro rata issue (except a bonus issue) is made to the holders of the underlying securities in the Company, the exercise price of the Annexure C Option may be reduced in accordance with ASX Listing Rule 6.22.

• (k) Reminder notices will be forwarded to the Annexure C Option holders prior to the expiry of the Annexure C Options. Annexure C Options not exercised before the expiry of the Annexure C Option Exercise Period will lapse.

• (l) The Annexure C Options will be recorded on the Company's register of Option holders maintained at the share registry. The register will be open for inspection by an Annexure C Option holder free of charge. Shares to be allotted on

35

exercise of Annexure C Options will be recorded on the Company's share register.

• (m) The Directors may seek quotation of the Annexure C Options on the ASX.

• (n) The Annexure C Option holder, if appearing on the Company's register of Option holders at the relevant date, will be entitled to receive and will be sent all reports and accounts required to be laid before Shareholders in general meeting and all notices of general meetings and will have the right to attend but shall have no right to vote at such meetings.

• (o) Notwithstanding paragraph (c), all Annexure C Options may be exercised prior to the relevant Annexure C Option Vesting Date:

• (i) in relation to a takeover bid in respect of the Shares, during the bid period, as defined in section 9 of the Corporations Act, provided that where a takeover bid is publicly announced prior to the service of a bidder's statement on the Company in relation to that takeover bid, the bid period will be deemed to have commenced at the date of that announcement;

• (ii) at any time after a Shareholder, or a group of associated Shareholders, becomes entitled to sufficient Shares to give it or them the ability, and that ability is successfully exercised, in general meeting, to replace all or a majority of the Directors;

• (iii) at any time after, on an application under section 411 of the Corporations Act, a court orders a meeting to be held concerning a proposed compromise or arrangement for the purposes of, or in connection with, a scheme for the reconstruction of the Company, or its amalgamation with any other company.

36

SCHEDULE 2 - INFORMATION REQUIRED BY LISTING RULE 7.3A.6 – RESOLUTION 11

	Issue 1	Issue 2
Date of issue:	17 December 2013	1 July 2013
Number issued:	3,500,000	5,400,000
Class/Type of equity security:	Ordinary shares	Ordinary shares
Summary of terms:	Issued to Directors in lieu of cash remuneration. Approved by shareholders 29 November 2012	Issue to advisor in lieu of cash payment of invoice of US$50,000
Names of persons who received securities or basis on which those persons was determined:	Guy Robertson – 2,500,000 George Frangeskides – 1,000,000	Somerley Limited
Price:	Deemed price of 1 cent per share	Deemed price of 1 cent per share
Discount to market price (if any):	N/A $0.007 at date of issue	N/A
For cash issues
Total cash consideration received:	Nil	Nil
Amount of cash consideration spent:	N/A	N/A
Use of cash consideration:	N/A	N/A
Intended use for remaining amount of cash (if any):	N/A	N/A

37

For non-cash issues
Non-cash consideration paid:	Shares issued as above	Shares issued as above
Current value of that non-cash consideration:	Directors valuation at 1 cent per share – or $35,000	Directors valuation at 1 cent per share – or $54,000 (US$50,000 per invoice)
	Issue 3	Issue 3
Date of issue:	2 September 2013	2 September 2013
Number issued:	196,116,158	98,058,079 Long dated 98,058,079 Short dated
Class/Type of equity security:	Ordinary shares	Listed options
Summary of terms:	Rights Issue. See ASX announcement 24 July 2013	Long dated exercise price 2 cents, expiry 31 August 2016 Short dated exercise price 1.2 cents, expiry 31 March 2013 Each option attached to shares on a one for two basis
Names of persons who received securities or basis on which those persons was determined:	Shareholders – on application – 155,262,206 Underwriters – placed with institutional and sophisticated investors 40,853,952 shares	Shareholders – attached to issue of shares – 77,631,103 short dated and 77,631,103 long dated options. Underwriters – placed with institutional and sophisticated investors 20,426,976 short dated options and 20,426,976 long dated options
Price:	$0.006 per share	Free attaching to shares
Discount to market price (if any):	40%	N/A

38

	Issue 3	Issue 3
For cash issues
Total cash consideration received:	$1,176,697	N/A
Amount of cash consideration spent:	$181,697
Use of cash consideration:	Broker fee placement $70,602 Drilling Eastern Hills $75,625 Administration and overheads $35,470
Intended use for remaining amount of cash (if any):	Remaining $995,000 $435,000 To fund the drilling programme, stages 1,2 and 3 at Eastern Hills antimony project. Administration and overhead $560,000
	Issue 4	Issue 4
Date of issue:	2 September 2013	2 September 2013
Number issued:	33,333,331	16,666,666 Long dated 16,666,666 Short dated
Class/Type of equity security:	Ordinary shares	Listed options
Summary of terms:	Placement. See ASX announcement dated 28 August 2013	Long dated exercise price 2 cents, expiry 31 August 2016 Short dated exercise price 1.2 cents, expiry 31 March 2013 Each option attached to shares on a one for

39

	Issue 4	Issue 4
		two basis
Names of persons who received securities or basis on which those persons was determined:	Placed with institutional and sophisticated investors as determined by Directors based on capacity to invest and add value to the Company.	Underwriters – placed with institutional and sophisticated investors as determined by Directors based on capacity to invest and add value to the Company.
Price:	$0.006 per share	Free attaching to shares
Discount to market price (if any):	40%	N/A
For cash issues
Total cash consideration received:	$200,000	N/A
Amount of cash consideration spent:	Placement fee $12,000
Use of cash consideration:	Placement fee - Broker
Intended use for remaining amount of cash (if any):	Remaining cash $188,000. To fund the drilling programme, stages 1,2 and 3 at Eastern Hills antimony project

	Issue 5	Issue 5
Date of issue:	12 September 2013	12 September 2013
Number issued:	24,244,520	24,244,518
Class/Type of equity security:	Ordinary shares	Listed options
Summary of terms:	Placement 12 September 2013 as announced to ASX 28 August 2013	12,122,259 Short Dated Options, price 1.2 cents expiry 31 March 2014 and 12,122,259 Long Dated Options,

40

	Issue 5	Issue 5
		price 2 cents expiry 31 August 2016. One Short Dated and one Long Dated option for every two shares issued under issue 1
Names of persons who received securities or basis on which those persons was determined:	Issued to institutional and sophisticated investors as Determined by Directors based on capacity to invest in and add value to the Company. No shares were issued to related parties.	Issued to institutional and sophisticated investors as Determined by Directors based on capacity to invest in and add value to the Company . No shares were issued to related parties.
Price:	$0.007	N/A. Free attaching options
Discount to market price (if any):	N/A - 15 day VWAP $0.0058	N/A
For cash issues
Total cash consideration received:	$169,712	N/A
Amount of cash consideration spent:	Placement fee $10,183	N/A
Use of cash consideration:	Placement fee – broker.
Intended use for remaining amount of cash (if any):	Remaining cash $159,529. To fund the drilling programme, stages 1,2 and 3 at Eastern Hills antimony project

41

==> picture [37 x 37] intentionally omitted <==

PROXY FORM

THIS DOCUMENT IS IMPORTANT. IF YOU ARE IN DOUBT AS TO HOW TO DEAL WITH IT, PLEASE CONTACT YOUR STOCK BROKER OR LICENSED PROFESSIONAL ADVISOR.

==> picture [37 x 37] intentionally omitted <==

ARTEMIS RESOURCES LTD

REGISTERED OFFICE:

ABN: 80 107 051 749

LEVEL 9 50 MARGARET STREET SYDNEY NSW 2000

==> picture [261 x 76] intentionally omitted <==

SHARE REGISTRY: Security Transfer Registrars Pty Ltd All Correspondence to: PO BOX 535, APPLECROSS WA 6953 AUSTRALIA 770 Canning Highway, APPLECROSS WA 6153 AUSTRALIA T: +61 8 9315 2333 F: +61 8 9315 2233 E: registrar@securitytransfer.com.au W: www.securitytransfer.com.au

==> picture [108 x 35] intentionally omitted <==

Code: Holder Number:

ARV

SECTION A: Appointment of Proxy

• I/We, the above named, being registered holders of the Company and entitled to attend and vote hereby appoint:

OR

The meeting Chairperson

(mark with an "X")

The name of the person you are appointing

(if this person is someone other than the Chairperson of the meeting).

or failing the person named, or if no person is named, the Chairperson of the Meeting, as my/our Proxy to act generally at the meeting on my/our behalf and to vote in accordance with the following directions (or if no directions have been given, as the Proxy sees fit) at the Annual General Meeting of the Company to be held at 3.00pm (EST) on Friday, 29 November 2013 in the Board Room of RSM Bird Cameron Partners at Level 12, 60 Castlereagh Street, Sydney NSW 2000 and at any adjournment of that meeting.

SECTION B: Voting Directions to your Proxy

Please mark "X" in the box to indicate your voting directions to your Proxy.

RESOLUTIONS

1. Adoption of Remuneration Report (non-binding vote)

2. Re-election of Director - George Frangeskides

3. Ratification of Prior Issue of 5,400,000 shares

4. Ratification of Prior Issue of 33,333,331 shares

5. Ratification of Prior Issue of 33,333,332 options

6. Approval to Issue 200,000,000 Shares

7. Approval to Issue 100,000,000 Options

8. Issue of Performance Rights to Executive Director - Guy Robertson

9. Issue of Performance Rights to Non- Executive Director - George Frangeskides

10. Issue of Performance Rights to Non- Executive Director - Shannon Coates

11. Approval of 10% Placement Issue

For Against Abstain*

==> picture [96 x 252] intentionally omitted <==

If no directions are given my proxy may vote as the proxy thinks fit or may abstain.

• If you mark the Abstain box for a particular item, you are directing your Proxy not to vote on your behalf on a show of hands or on a poll and your votes will not be counted in computing the required majority on a poll.

If you wish to appoint the Chairperson as your proxy and you do not wish to direct the Chairperson how to vote, please mark "X" in the box.

• By marking this box, you acknowledge that the Chairperson may exercise your proxy even if he has an interest in the outcome of Resolutions 8, 9 and 10 and votes cast by him/her other than as a proxy holder will be disregarded because of that interest. If you do not mark this box, and you have not directed your proxy how to vote, the Chair will not cast your votes on Resolutions 8, 9 and 10 and your votes will not be counted in calculating the required majority if a poll is called on Resolutions 8, 9 and 10 . The Chairperson of the Meeting intends to vote undirected proxies in favour of Resolutions 8, 9 and 10.

SECTION C: Please Sign Below

This section must be signed in accordance with the instructions overleaf to enable your directions to be implemented. Individual or Security Holder Security Holder 2

Security Holder 3

Sole Director and Sole Company Secretary

Director / Company Secretary

Reference Number:

Director

0416645141

ARV

1

1

My/Our contact details in case of enquiries are: NAME

==> picture [37 x 37] intentionally omitted <==

==> picture [37 x 37] intentionally omitted <==

TELEPHONE NUMBER ( )

NOTES

1. Name and Address

This is the name and address on the Share Register of ARTEMIS RESOURCES LTD. If this information is incorrect, please make corrections on this form. Shareholders sponsored by a broker should advise their broker of any changes. Please note that you cannot change ownership of your shares using this form.

2. Appointment of a Proxy

If you wish to appoint the Chairperson of the Meeting as your Proxy please mark "X" in the box in Section A. Please also refer to Section B of this proxy form and ensure you mark the box in that section if you wish to appoint the Chairperson as your Proxy.

If the person you wish to appoint as your Proxy is someone other than the Chairperson of the Meeting please write the name of that person in Section A. If you leave this section blank, or your named Proxy does not attend the meeting, the Chairperson of the Meeting will be your Proxy. A Proxy need not be a ARTEMIS RESOURCES LTD.

3. Directing your Proxy how to vote

To direct the Proxy how to vote place an "X" in the appropriate box against each item in Section B. Where more than one Proxy is to be appointed and the proxies are to vote differently, then two separate forms must be used to indicate voting intentions.

4. Appointment of a Second Proxy

You are entitled to appoint up to two (2) persons as proxies to attend the meeting and vote on a poll. If you wish to appoint a second Proxy, an additional Proxy form may be obtained by telephoning the Company's share registry +61 8 9315 2333 or you may photocopy this form.

To appoint a second Proxy you must:

• (a) On each of the Proxy forms, state the percentage of your voting rights or number of securities applicable to that form. If the appointments do not specify the percentage or number of votes that each Proxy may exercise, each Proxy may exercise half of your votes; and

• (b) Return both forms in the same envelope.

5. Signing Instructions Individual: where the holding is in one name, the Shareholder must sign.

Joint Holding: where the holding is in more than one name, all of the Shareholders must sign.

Power of Attorney: to sign under Power of Attorney you must have already lodged this document with the Company's share registry. If you have not previously lodged this document for notation, please attach a certified photocopy of the Power of Attorney to this form when you return it.

Companies: where the Company has a Sole Director who is also the Sole Company Secretary, this form must be signed by that person. If the Company (pursuant to section 204A of the Corporations Act 2001) does not have a Company Secretary, a Sole Director may sign alone. Otherwise this form must be signed by a Director jointly with either another Director or Company Secretary. Please indicate the office held in the appropriate place.

If a representative of the corporation is to attend the meeting the appropriate "Certificate of Appointment of Corporate Representative" should be lodged with the Company before the meeting or at the registration desk on the day of the meeting. A form of the certificate may be obtained from the Company's share registry.

6. Lodgement of Proxy

Proxy forms (and any Power of Attorney under which it is signed) must be received by Security Transfer Registrars Pty Ltd no later than 3.00pm (EST) on Wednesday, 27 November 2013, being 48 hours before the time for holding the meeting. Any Proxy form received after that time will not be valid for the scheduled meeting.

Security Transfer Registrars Pty Ltd PO BOX 535 Applecross, Western Australia 6953

Street Address: Alexandrea House, Suite 1 770 Canning Highway Applecross, Western Australia 6153

Telephone +61 8 9315 2333 Facsimile +61 8 9315 2233 Email registrar@securitytransfer.com.au

PRIVACY STATEMENT

Personal information is collected on this form by Security Transfer Registrars Pty Ltd as the registrar for securities issuers for the purpose of maintaining registers of securityholders, facilitating distribution payments and other corporate actions and communications. Your personal details may be disclosed to related bodies corporate, to external service providers such as mail and print providers, or as otherwise required or permitted by law. If you would like details of your personal information held by Security Transfer Registrars Pty Ltd or you would like to correct information that is inaccurate please contact them on the address on this form.

==> picture [37 x 37] intentionally omitted <==

==> picture [37 x 37] intentionally omitted <==

1329645145